Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	651	1,299	2,269	2,506	4,502	3,741
Market Cap Growth	-55.05%	-42.73%	-9.45%	-44.34%	20.36%	-16.71%
Enterprise Value	-65	550	1,007	781	2,429	2,767
PE Ratio	-	-2.40	-4.26	-5.47	7.43	-5.50
PS Ratio	7.15	15.03	295.22	397.27	4.04	544.66
PB Ratio	0.92	1.63	1.81	1.45	2.17	3.96
P/FCF Ratio	-2.65	-2.40	-4.92	-6.62	6.78	-7.00
P/OCF Ratio	-2.65	-2.40	-4.93	-6.63	6.78	-7.08
EV/Sales Ratio	4.50	6.36	131.08	123.78	2.18	402.89
EV/EBITDA Ratio	-0.82	-1.02	-1.89	-1.72	3.99	-4.08
EV/EBIT Ratio	-0.81	-1.02	-1.89	-1.71	4.01	-4.07
EV/FCF Ratio	-0.96	-1.02	-2.19	-2.06	3.66	-5.18
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.01	0.04
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	-0.04	0.05	-0.05
Debt / FCF Ratio	-0.01	-0.01	-0.03	-0.05	0.04	-0.07
Quick Ratio	11.82	10.12	12.97	20.68	31.27	9.01
Current Ratio	12.22	10.51	13.47	21.14	31.58	9.23
Asset Turnover	0.10	0.08	0.01	0.00	0.95	0.01
Return on Equity (ROE)	-60.90%	-58.00%	-37.00%	-24.40%	56.10%	-59.80%
Return on Assets (ROA)	-54.70%	-52.40%	-34.70%	-23.30%	51.90%	-54.10%
Return on Capital (ROIC)	-76.44%	-72.06%	-43.25%	-26.38%	28.39%	-72.13%
Earnings Yield	-77.27%	-41.67%	-23.48%	-18.27%	13.46%	-18.18%
FCF Yield	-65.28%	-41.64%	-20.32%	-15.11%	14.75%	-14.29%
Buyback Yield / Dilution	-0.77%	-0.89%	-1.08%	-10.69%	-4.27%	-10.22%
Total Shareholder Return	-0.77%	-0.89%	-1.08%	-10.69%	-4.27%	-10.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).